Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Advanced Solid Tumors × eribulin × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 24 Triple Negative Breast Neoplasms 10 Sarcoma 5 Neoplasm Metastasis 5 Liposarcoma 3 Inflammatory Breast Neoplasms 3 Urinary Bladder Neoplasms 2 Leiomyosarcoma 2 Carcinoma, Transitional Cell 2 Uterine Cervical Neoplasms 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Refractory Solid Tumors 1 Recurrence 1 Ketosis 1 Histiocytoma, Malignant Fibrous 1 Hemangiosarcoma 1 Hemangioendothelioma, Epithelioid 1 HR+HER2- Breast Cancer 1 HER2-negative Metastatic Breast Cancer 1 HER2-low Breast Cancer 1 Fludzoparib" and Anti-angiogenic 1 Colorectal Neoplasms 1 Brest Cancer 1 Brain Neoplasms 1 Advanced Breast Cancer 1

Interventions

Injections 16 Carboplatin 8 pembrolizumab 7 Bevacizumab 7 Leucovorin 6 Fluorouracil 6 Docetaxel 5 Pemetrexed 4 Paclitaxel 4 Oxaliplatin 4 trifluridine tipiracil drug combination 3 atezolizumab 3 Capecitabine 3 tislelizumab 2 spartalizumab 2 sotorasib 2 palbociclib 2 olaparib 2 fludarabine 2 Panitumumab 2 Irinotecan 2 HMPL-013 2 Fulvestrant 2 Etoposide 2 Drug Therapy 2 Cyclophosphamide 2 Cisplatin 2 Cetuximab 2 130-nm albumin-bound paclitaxel 2 zimberelimab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡